StreetInsider.com News Articles

Form 425 Onconetix, Inc. Filed by: Onconetix, Inc.

Tue, 27 Oct 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20261027/27237420.html

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Tue, 27 Oct 2026 08:30:00 -0400

Echo Tabletop Priced at $11,950 and Echo Full Body at $59,950; First Production Run of 250 Units Available for 2027 Delivery; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.

CINCINNATI, Ohio , Oct. 27, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) is providing the following summary of a press release issued by Realbotix Corp., parent of Realbotix LLC (“Realbotix”), the target of Onconetix’s previously announced pending acquisition.

On October 26, 2026, Realbotix announced the official launch of Echo, its

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Tue, 27 Oct 2026 08:30:00 -0400

On October 26, 2026, Realbotix announced the official launch of Echo, its

Form 8-K Onconetix, Inc. For: Oct 22

Mon, 26 Oct 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20261026/27234857.html

Onconetix announces 1-for-10 reverse stock split effective Nov. 6

Mon, 26 Oct 2026 17:03:08 -0400

Onconetix, Inc. (Nasdaq: ONCO) announced that its Board of Directors has approved a one-for-ten reverse stock split of the company's outstanding common stock, according to a press release.

The reverse split is set to take effect at 12:01 a.m. Eastern Time on November 6, 2026. Every ten shares of common stock will be automatically exchanged into one share. The company's stock will continue to trade on Nasdaq under the ticker symbol "ONCO," and a new CUSIP number, 68237Q500, has been assigned in connection with the split.

The reverse split will reduce outstanding shares from approximately 5,886,774 shares, as of October 21, 2026,

Onconetix Announces Reverse Stock Split

Mon, 26 Oct 2026 17:03:00 -0400

CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common stock. The reverse split is expected to become effective at 12:01 a.m. Eastern Time on November 6, 2026. The Company’s common stock has been assigned a new CUSIP number, 68237Q500, in connection with the reverse stock split.

Following the reverse split, every ten (10) shares of Onconetix common stock will be automatically exchanged into one share of common stock. The

Onconetix Announces Reverse Stock Split

Mon, 26 Oct 2026 17:03:00 -0400

Following the reverse split, every ten (10) shares of Onconetix common stock will be automatically exchanged into one share of common stock. The

Form DEFA14A Onconetix, Inc.

Fri, 23 Oct 2026 11:43:00 -0400

si-local-file:///var/storage/secattach/20261023/27226705.html

Form 8-K Onconetix, Inc. For: Oct 22

Fri, 23 Oct 2026 11:40:00 -0400

si-local-file:///var/storage/secattach/20261023/27226693.html

Form 425 Onconetix, Inc. Filed by: Onconetix, Inc.

Fri, 23 Oct 2026 09:22:00 -0400

si-local-file:///var/storage/secattach/20261023/27225812.html

Onconetix advances $500K more to Realbotix, total now $3M

Fri, 23 Oct 2026 08:30:53 -0400

Onconetix, Inc. (Nasdaq: ONCO) has made an additional $500,000 advance to Realbotix LLC under a strategic bridge financing facility, bringing the total principal outstanding to $3,000,000, according to a press release dated Oct. 23, 2026.

The financing facility, referred to as the Grid Note, allows for aggregate loans of up to $5,000,000 and carries no interest prior to the closing of a pending Share Exchange Agreement between the two companies. Upon closing, the Grid Note and all obligations under it will be automatically cancelled and discharged in full. The cash required at closing will be reduced by the total principal advanced

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Fri, 23 Oct 2026 08:30:00 -0400

Additional $500,000 Advance to Support Growth Initiatives and Working Capital of Realbotix LLC

Total Drawn Under Facility Now $3,000,000; Non-Interest Bearing Facility Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition

CINCINNATI, Ohio, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) today announced that it has made an additional advance of $500,000 to Realbotix LLC (“Realbotix”), the target of its previously announced pending acquisition, under the strategic bridge financing facility (the “Grid Note”) announced on September 14, 2026. The additional advance brings the

Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition

Fri, 23 Oct 2026 08:30:00 -0400

Additional $500,000 Advance to Support Growth Initiatives and Working Capital of Realbotix LLC

Total Drawn Under Facility Now $3,000,000; Non-Interest Bearing Facility Automatically Cancelled and Discharged in Full Upon Closing of Pending Acquisition

Form ARS Onconetix, Inc. For: Dec 31

Fri, 16 Oct 2026 09:11:00 -0400

si-local-file:///var/storage/secattach/20261016/27196265.html

Form DEF 14A Onconetix, Inc. For: Nov 10

Wed, 07 Oct 2026 11:29:00 -0400

si-local-file:///var/storage/secattach/20261007/27159891.html

SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)